CPT® Code 82554

Official Description

Creatine kinase (CK), (CPK); isoforms

Common Language Description

Creatine kinase (CK), also referred to as creatine phosphokinase (CPK), is an important enzyme that plays a critical role in energy production within various tissues of the body, particularly in the heart, brain, and skeletal muscle. This enzyme exists in different isoforms, which are specific variants that can be found in distinct tissues. The primary isoforms include CK-MM, predominantly located in skeletal and heart muscle, CK-MB, which is primarily found in heart muscle, and CK-BB, located in the brain. In the bloodstream, CK levels are typically composed of CK-MM and CK-MB, with CK-BB being present only in minimal amounts. Elevated levels of CK in the blood can indicate damage to heart muscle, such as that occurring during a heart attack (myocardial infarction), or injury to skeletal muscle, which may result from trauma or intense physical activity. Additionally, certain factors such as the use of statin medications, which are designed to lower cholesterol levels, and alcohol consumption can also lead to increased CK levels in the blood. The measurement of total creatine kinase levels is performed through a blood test, which is reported under CPT® code 82550, while isoenzyme levels are assessed under CPT® code 82552. The specific measurement of the CK-MB fraction is captured under CPT® code 82553. CPT® code 82554 focuses on the analysis of CK isoforms, which are the breakdown products of the CK isoenzymes. This testing is crucial for determining the precise location and timing of muscle injury, as the CK-MM isoenzyme can break down into at least three major isoform subtypes, while CK-MB can break down into at least two. Blood specimens for these tests are obtained through a separately reportable venipuncture, and the serum may be analyzed using various advanced techniques, including high-resolution electrophoresis, isoelectric focusing, chromatofocusing, and liquid chromatography.

1. Indications

The measurement of creatine kinase (CK) isoforms is indicated in various clinical scenarios where muscle damage is suspected. The following conditions may warrant this testing:

Heart Muscle Damage: Elevated CK levels can indicate myocardial infarction or other forms of heart muscle injury.
Skeletal Muscle Injury: Conditions such as trauma or vigorous exercise that may lead to muscle damage can prompt the need for CK isoform testing.
Monitoring of Muscle Disorders: Patients with known muscle disorders may require periodic assessment of CK isoforms to evaluate disease progression or response to treatment.
Assessment of Statin Effects: Patients on statin therapy may be monitored for elevated CK levels as a side effect of the medication.

2. Procedure

The procedure for measuring creatine kinase (CK) isoforms involves several key steps to ensure accurate results. First, a blood specimen is obtained from the patient through a venipuncture, which is a standard method for collecting blood samples. This step is crucial as it provides the serum needed for testing. Once the blood is collected, it is processed to separate the serum from the cellular components. The serum is then subjected to various analytical techniques to measure the levels of CK isoforms. These techniques may include high-resolution electrophoresis, which separates proteins based on their size and charge, isoelectric focusing, which separates proteins based on their isoelectric point, chromatofocusing, and liquid chromatography, which further refines the separation of isoforms. Each of these methods allows for the identification and quantification of the specific CK isoforms, CK-MM and CK-MB, and their respective subtypes. The results of this testing can provide valuable information regarding the timing and location of muscle injury, aiding in the diagnosis and management of the patient's condition.

3. Post-Procedure

After the procedure, patients may be advised to resume normal activities unless otherwise directed by their healthcare provider. There are typically no specific post-procedure care requirements following a venipuncture, although patients may be monitored for any immediate adverse reactions, such as bruising or discomfort at the puncture site. The results of the CK isoform testing will be interpreted by the healthcare provider, who will discuss the findings with the patient and determine any necessary follow-up actions based on the results. It is important for patients to understand that elevated CK isoform levels may require further investigation to identify the underlying cause of muscle damage.

Short Descr	CREATINE ISOFORMS
Medium Descr	CREATINE KINASE ISOFORMS
Long Descr	Creatine kinase (CK), (CPK); isoforms
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
CLIA Waived (QW)	No
APC Status Indicator	Conditionally packaged laboratory tests
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T1H - Lab tests - other (non-Medicare fee schedule)
MUE	1
CCS Clinical Classification	233 - Laboratory - Chemistry and Hematology